U.S. Cord Blood Banking Services Market Analysis By Bank Type, By Component (Cord Blood, Tissue, Placenta), By States (Texas, Arizona, California, Florida, Kentucky, New Jersey), And Segment Forecasts, 2014 - 2025

Published: Dec, 2017 | Pages: 80 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)

The U.S. cord blood banking market is expected to reach USD 49.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing awareness regarding long term benefits of cord blood storage, increasing number of service providers, reduction in cost involved in storage, and growing investment in public banking are the factors driving the market growth in the country.

The U.S. cord blood banking market captures a significant share of the global cord blood banking industry. Factors such as high adoption rate for advanced technologies, growing per capita income, and increasing number of storage service providers can be attributable to the largest market share.

Growing applications of cord blood in the treatment of several chronic disorders is expected to fuel the market. Currently cord blood is approved for usage in around 80 diseases. These disease include degenerative disorders such as cancers, immunodeficiency related disorders, and bone marrow disorders. Growing prevalence of such diseases and need for effective therapeutic treatments are expected to boost the number of units stored.  A large number of ongoing clinical trials in phase II, III, and IV are showing a potential growth opportunity in the near future.

Further Key Findings from the Report Suggest:

• Private banking currently captures the largest revenue share and is expected to dominate the market throughout the forecast period

• Large number of parents opting for private banking, high prices involved in collection, transport and storage, and increasing number of these type of service provides are the prime factors expected to result in swift growth of the segment during the forecast period

• Increasing awareness, high government investment, and efforts to store genetically diverse cord blood units are the factors expected to boost the segment growth of public banking

• Cord blood captured the largest market share in 2016 over cord tissue and placenta. Relatively easy license acquisition, affordability, and ease of storage are the factors driving the segment share.

• Key market players include California Cryobank Stem Cell Services LLC; Cord Blood America, Inc.; StemCyte, Inc.; Norton Healthcare, Inc.; Cryo-Cell International, Inc., and Lifeforce Cryobank Sciences Inc.

 Table of Contents

Chapter 1 Research Methodology
                 1.1 Information procurement
                 1.2 Information or Data Analysis
                     1.2.1 Market Formulation & Validation
                 1.3 Region Wise Market Calculation
                     1.3.1 Region Wise Market: Base Estimates
                     1.3.2 Global Market: CAGR Calculation
                 1.4 List of Secondary Sources

Chapter 2 Executive Summary
                 2.1 Market Snapshot

Chapter 3 U.S. Cord Blood Banking Services Market Variables, Trends & Scope
                 3.1 Market segmentation & scope
                     3.1.1 Market Driver Analysis
                         3.1.1.1 Rising application of cord blood in treatment of chronic conditions
                         3.1.1.2 Rising focus of federal agencies to set up public banking units
                         3.1.1.3 Growing awareness regarding this treatment line
                         3.1.1.4 Increasing number of facilities across the region
                     3.1.2 Market Restraint Analysis
                         3.1.2.1 High cost and probability of non-usage
                         3.1.2.2 Market is highly driven by recommendation made by gynecologists
                 3.2 Penetration & growth prospect mapping
                 3.3 U.S. Cord Blood Banking Services Market -SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
                 3.4 Industry Analysis -Porter's
                 3.5 Opportunity Analysis
                     3.5.1 Opportunity Analysis: Placenta Storage
                     3.5.2 Opportunity Analysis: Potential usage of Cord Tissue and Placenta Tissue in Regenerative Medicine Using Stem Cells
                 3.6 Respository Analysis, By Bank Type, 2016

Chapter 4 U.S. Cord Blood Banking Services Market: Bank Type Estimates & Trend Analysis
                 4.1 U.S. cord blood banking services market: Bank type movement analysis
                 4.2 Private banks
                     4.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion)
                     4.2.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units)
                 4.3 Public bank
                     4.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion)
                     4.3.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units)
                 4.4 Hybrid
                     4.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion)
                     4.4.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units)

Chapter 5 U.S. Cord Blood Banking Services Market: Blood Component Estimates & Trend Analysis
                 5.1 U.S. cord blood banking services market: Blood component movement analysis
                 5.2 Cord blood
                     5.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion)
                     5.2.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units)
                 5.3 Cord tissue
                     5.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion)
                     5.3.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units)
                 5.4 Placenta
                     5.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion)
                     5.4.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units)

Chapter 6 U.S. Cord Blood Banking Services Market: Regional Estimates & Trend Analysis, By Bank Type & Blood Component
                 6.1 U.S.
                     6.1.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion) 
                     6.1.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
                 6.2 Arizona
                     6.2.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
                     6.2.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
                 6.3 California
                     6.3.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
                     6.3.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
                 6.4 Florida
                     6.4.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
                     6.4.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
                 6.5 Kentucky
                     6.5.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
                     6.5.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
                 6.6 New Jersey
                     6.6.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
                     6.6.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
                 6.7 Texas
                     6.7.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
                     6.7.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
                 6.8 Houston
                     6.8.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
                     6.8.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
                 6.9 Massachusetts
                     6.9.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
                     6.9.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)

Chapter 7 Competitive Landscape
                 7.1 Strategy framework
                 7.2 Competitive Heat Map Analysis, by Region, 2016
                 7.3 Company Profiles
                     7.3.1 Cord Blood America, Inc.
                         7.3.1.1 Company overview
                         7.3.1.2 Financial performance
                         7.3.1.3 Product benchmarking
                         7.3.1.4 Strategic initiatives
                     7.3.2 California Cryobank Stem Cell Services, LLC.
                         7.3.2.1 Company overview
                         7.3.2.2 Financial performance
                         7.3.2.3 Product benchmarking
                         7.3.2.4 Strategic initiatives
                     7.3.3 StemCyte Inc.
                         7.3.3.1 Company overview
                         7.3.3.2 Financial performance
                         7.3.3.3 Product benchmarking
                         7.3.3.4 Strategic initiatives
                     7.3.4 Cryo-Cell International, Inc.
                         7.3.4.1 Company overview
                         7.3.4.2 Financial performance
                         7.3.4.3 Product benchmarking
                         7.3.4.4 Strategic initiatives
                     7.3.5 Lifeforce Cryobank Sciences, Inc.
                         7.3.5.1 Company overview
                         7.3.5.2 Financial performance
                         7.3.5.3 Product benchmarking
                     7.3.6 Stem Cell Cryobank Inc.
                         7.3.6.1 Company overview
                         7.3.6.2 Financial performance
                         7.3.6.3 Product benchmarking
                     7.3.7 Norton Healthcare
                         7.3.7.1 Company overview
                         7.3.7.2 Financial performance
                         7.3.7.3 Product benchmarking
                         7.3.7.4 Strategic initiatives
                     7.3.8 Viacord Processing Laboratory (VPL)
                         7.3.8.1 Company overview
                         7.3.8.2 Financial performance
                         7.3.8.3 Product benchmarking
                         7.3.8.4 Strategic initiatives
                     7.3.9 New Jersey Cord Blood Bank
                         7.3.9.1 Company overview
                         7.3.9.2 Financial performance
                         7.3.9.3 Product benchmarking
                         7.3.9.4 Strategic initiatives
                     7.3.10 Carter BloodCare
                         7.3.10.1 Company overview
                         7.3.10.2 Financial performance
                         7.3.10.3 Product benchmarking
                         7.3.10.4 Strategic initiatives
                     7.3.11 Americord Registry
                         7.3.11.1 Company overview
                         7.3.11.2 Financial performance
                         7.3.11.3 Product benchmarking
                         7.3.11.4 Strategic initiatives

List of Tables

TABLE 1 List of potential usage of cord blood
TABLE 2 Legislation implication in various states of the U.S. for cord blood banking services
TABLE 3 Cord Blood Facilities with AABB accreditation in the U.S.
TABLE 4 Differentiation potential of human placenta and amniotic fluid mesenchymal stem cells
TABLE 5 Private bank market, by volume, 2014 - 2025 (No. of Units)
TABLE 6 Public bank market, by volume, 2014 - 2025 (No. of Units)
TABLE 7 Hybrid market, by volume, 2014 - 2025 (No. of Units)
TABLE 8 U.S. cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
TABLE 9 U.S. cord blood banking services market, by blood component, 2014 - 2025 (USD Billion)
TABLE 10 Arizona cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
TABLE 11 California cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
TABLE 12 Florida cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
TABLE 13 Kentucky cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
TABLE 14 New Jersey cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
TABLE 15 Texas cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
TABLE 16 Houston cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
TABLE 17 Massachusetts cord blood banking services market, by bank type, 2014 - 2025 (USD Billion

List of Figures

FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary, 2016 (USD Billion)
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping, by Service
FIG. 13 Penetration & growth prospect mapping, by Component
FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 15 Porter's Five Forces Analysis
FIG. 16 Opportunity Analysis: Placenta Storage
FIG. 17 Differentiation potential of human placenta and umbilical cord blood stem cells
FIG. 18 Repository Analysis
FIG. 19 U.S. cord blood banking services market: Bank type outlook key takeaways
FIG. 20 U.S. cord blood banking services market: Bank type movement analysis
FIG. 21 Private bank market, 2014 - 2025 (USD Billion)
FIG. 22 Public bank market, 2014 - 2024 (USD Billion)
FIG. 23 Hybrid market, 2014 - 2024 (USD Billion)
FIG. 24 U.S. cord blood banking services market: Blood component outlook key takeaways
FIG. 25 U.S. cord blood banking services market: Blood component movement analysis
FIG. 26 Cord blood market, 2014 - 2024 (USD Billion)
FIG. 27 Cord tissue market, 2014 - 2025 (USD Billion)
FIG. 28 Placenta market, 2014 - 2025 (USD Billion)
FIG. 29 U.S. cord blood banking services market: Regional outlook key takeaways
FIG. 30 U.S. market, 2014 - 2025 (USD Billion)
FIG. 31 Arizona market, 2014 - 2025 (USD Billion)
FIG. 32 California market, 2014 - 2025 (USD Billion)
FIG. 33 Florida market, 2014 - 2025 (USD Billion)
FIG. 34 Kentucky market, 2014 - 2025 (USD Billion)
FIG. 35 New Jersey market, 2014 - 2025 (USD Billion)
FIG. 36 Texas market, 2014 - 2025 (USD Billion)
FIG. 37 Houston market, 2014 - 2025 (USD Billion)
FIG. 38 Massachusetts market, 2014 - 2025 (USD Billion)
FIG. 39 Strategy framework
FIG. 40 Heat map